Hove Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Hove Pharma
Largest movements
- Receivables within one year +€33,402
up €33,402 (+34.5%), from €96,769 to €130,171
of which Trade receivables: +€23,336
- Intangible fixed assets -€28,500
down €28,500 (-20.0%), from €142,500 to €114,000
- Stocks and contracts +€16,914
up €16,914 (+12.1%), from €139,579 to €156,493
- Cash +€12,591
up €12,591 (+98.9%), from €12,735 to €25,326
mainly Depreciation (+€62,628) and Net result for the year (+€51,083)
- Debts after one year -€57,108
down €57,108 (-12.7%), from €450,439 to €393,332
- Trade debts +€46,196
up €46,196 (+47.1%), from €98,151 to €144,347
- Reserves +€37,083
up €37,083 (+33.6%), from €110,473 to €147,556
- Other debts +€13,150
up €13,150 (+328.8%), from €4,000 to €17,150
- Gross operating margin +€55,348
up €55,348 (+38.6%), from €143,467 to €198,814
- Staff costs +€27,847
up €27,847 (+95.6%), from €29,143 to €56,990
- Taxes +€11,495
up €11,495 (+682.3%), from €1,685 to €13,179
- Financial charges -€4,543
down €4,543 (-23.2%), from €19,548 to €15,005
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €806,526 | €849,286 | +€42,759 | +5.3% |
| Fixed assets | 21/28 | €555,450 | €534,898 | -€20,552 | -3.7% |
| Intangible fixed assets | 21 | €142,500 | €114,000 | -€28,500 | -20.0% |
| Tangible fixed assets | 22/27 | €412,950 | €420,898 | +€7,948 | +1.9% |
| Land and buildings | 22 | €343,376 | €323,776 | -€19,600 | -5.7% |
| Plant, machinery and equipment | 23 | €69,574 | €57,218 | -€12,356 | -17.8% |
| Other tangible fixed assets | 26 | - | €39,904 | +€39,904 | |
| Current assets | 29/58 | €251,076 | €314,388 | +€63,312 | +25.2% |
| Stocks and contracts in progress | 3 | €139,579 | €156,493 | +€16,914 | +12.1% |
| Stocks | 30/36 | €139,579 | €156,493 | +€16,914 | +12.1% |
| Amounts receivable within one year | 40/41 | €96,769 | €130,171 | +€33,402 | +34.5% |
| Trade receivables | 40 | €71,669 | €95,005 | +€23,336 | +32.6% |
| Other amounts receivable | 41 | €25,100 | €35,165 | +€10,066 | +40.1% |
| Cash at bank and in hand | 54/58 | €12,735 | €25,326 | +€12,591 | +98.9% |
| Deferred charges and accrued income | 490/1 | €1,993 | €2,398 | +€405 | +20.3% |
| Total equity and liabilities | 10/49 | €806,526 | €849,286 | +€42,759 | +5.3% |
| Equity | 10/15 | €190,473 | €227,556 | +€37,083 | +19.5% |
| Contributions | 10/11 | €80,000 | €80,000 | = | 0.0% |
| Reserves | 13 | €110,473 | €147,556 | +€37,083 | +33.6% |
| Distributable reserves | 133 | €110,473 | €147,556 | +€37,083 | +33.6% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €616,053 | €621,730 | +€5,676 | +0.9% |
| Amounts payable after more than one year | 17 | €450,439 | €393,332 | -€57,108 | -12.7% |
| Financial debts | 170/4 | €450,439 | €393,332 | -€57,108 | -12.7% |
| Amounts payable within one year | 42/48 | €162,735 | €226,334 | +€63,600 | +39.1% |
| Current portion of amounts payable after more than one year | 42 | €56,508 | €57,108 | +€600 | +1.1% |
| Trade debts | 44 | €98,151 | €144,347 | +€46,196 | +47.1% |
| Suppliers | 440/4 | €98,151 | €144,347 | +€46,196 | +47.1% |
| Taxes, remuneration and social security | 45 | €4,075 | €7,730 | +€3,654 | +89.7% |
| Taxes | 450/3 | €0 | €197 | +€197 | |
| Remuneration and social security | 454/9 | €4,075 | €7,533 | +€3,458 | +84.8% |
| Other amounts payable | 47/48 | €4,000 | €17,150 | +€13,150 | +328.8% |
| Accrued charges and deferred income | 492/3 | €2,879 | €2,064 | -€816 | -28.3% |
| Remuneration, social security and pensions | 62 | €29,143 | €56,990 | +€27,847 | +95.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €60,719 | €62,628 | +€1,909 | +3.1% |
| Other operating charges | 640/8 | €600 | €338 | -€262 | -43.7% |
| Gross operating margin | 9900 | €143,467 | €198,814 | +€55,348 | +38.6% |
| Operating profit (loss) | 9901 | €53,005 | €78,858 | +€25,854 | +48.8% |
| Financial income | 75/76B | €544 | €409 | -€136 | -24.9% |
| Recurring financial income | 75 | €544 | €409 | -€136 | -24.9% |
| Financial charges | 65/66B | €19,548 | €15,005 | -€4,543 | -23.2% |
| Recurring financial charges | 65 | €19,548 | €15,005 | -€4,543 | -23.2% |
| Profit (loss) for the period before taxes | 9903 | €34,001 | €64,262 | +€30,261 | +89.0% |
| Income taxes | 67/77 | €1,685 | €13,179 | +€11,495 | +682.3% |
| Profit (loss) for the period | 9904 | €32,317 | €51,083 | +€18,766 | +58.1% |
| Profit (loss) for the period to be appropriated | 9905 | €32,317 | €51,083 | +€18,766 | +58.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.